Modulation of irinotecan with cyclosporine: a phase II trial in advanced colorectal cancer.

Saved in:
Bibliographic Details
Title: Modulation of irinotecan with cyclosporine: a phase II trial in advanced colorectal cancer.
Authors: Desai AA; Section of Hematology/Oncology, University of Chicago, 5841 S. Maryland Avenue, MC 2115, Chicago, IL 60637, USA. adesai@medicine.bsd.uchicago.edu, Kindler HL, Taber D, Agamah E, Mani S, Wade-Oliver K, Ratain MJ, Vokes EE
Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2005 Oct; Vol. 56 (4), pp. 421-6. Date of Electronic Publication: 2005 May 13.
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0344-5704 (Print) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0344-5704
DOI:10.1007/s00280-005-1020-5